Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Do not discard Staphylococcus aureus WTA as a vaccine antigen.

van Dalen R, Molendijk MM, Ali S, van Kessel KPM, Aerts P, van Strijp JAG, de Haas CJC, Codée J, van Sorge NM.

Nature. 2019 Aug;572(7767):E1-E2. doi: 10.1038/s41586-019-1416-8. Epub 2019 Jul 31. No abstract available.

PMID:
31367020
2.

Immune Evasion by Staphylococcus aureus.

de Jong NWM, van Kessel KPM, van Strijp JAG.

Microbiol Spectr. 2019 Mar;7(2). doi: 10.1128/microbiolspec.GPP3-0061-2019. Review.

PMID:
30927347
3.

Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages.

Nissilä E, Hakala P, Leskinen K, Roig A, Syed S, Van Kessel KPM, Metso J, De Haas CJC, Saavalainen P, Meri S, Chroni A, Van Strijp JAG, Öörni K, Jauhiainen M, Jokiranta TS, Haapasalo K.

Front Immunol. 2018 Nov 21;9:2701. doi: 10.3389/fimmu.2018.02701. eCollection 2018.

4.

Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.

Haapasalo K, Wollman AJM, de Haas CJC, van Kessel KPM, van Strijp JAG, Leake MC.

FASEB J. 2019 Mar;33(3):3807-3824. doi: 10.1096/fj.201801910R. Epub 2018 Dec 3.

5.

Antibacterial and immunogenic behavior of silver coatings on additively manufactured porous titanium.

Croes M, Bakhshandeh S, van Hengel IAJ, Lietaert K, van Kessel KPM, Pouran B, van der Wal BCH, Vogely HC, Van Hecke W, Fluit AC, Boel CHE, Alblas J, Zadpoor AA, Weinans H, Amin Yavari S.

Acta Biomater. 2018 Nov;81:315-327. doi: 10.1016/j.actbio.2018.09.051. Epub 2018 Sep 28.

PMID:
30268917
6.

Publisher Correction: Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Tromp AT, Van Gent M, Abrial P, Martin A, Jansen JP, De Haas CJC, Van Kessel KPM, Bardoel BW, Kruse E, Bourdonnay E, Boettcher M, McManus MT, Day CJ, Jennings MP, Lina G, Vandenesch F, Van Strijp JAG, Lebbink RJ, Haas PA, Henry T, Spaan AN.

Nat Microbiol. 2018 Oct;3(10):1187. doi: 10.1038/s41564-018-0247-y.

PMID:
30177744
7.

Staphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2.

Zhao Y, van Kessel KPM, de Haas CJC, Rogers MRC, van Strijp JAG, Haas PA.

Cell Microbiol. 2018 Nov;20(11):e12941. doi: 10.1111/cmi.12941. Epub 2018 Sep 17.

8.

Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Tromp AT, Van Gent M, Abrial P, Martin A, Jansen JP, De Haas CJC, Van Kessel KPM, Bardoel BW, Kruse E, Bourdonnay E, Boettcher M, McManus MT, Day CJ, Jennings MP, Lina G, Vandenesch F, Van Strijp JAG, Lebbink RJ, Haas PA, Henry T, Spaan AN.

Nat Microbiol. 2018 Jun;3(6):708-717. doi: 10.1038/s41564-018-0159-x. Epub 2018 May 7. Erratum in: Nat Microbiol. 2018 Oct;3(10):1187.

PMID:
29736038
9.

Identification and structural characterization of a novel myeloperoxidase inhibitor from Staphylococcus delphini.

Ploscariu NT, de Jong NWM, van Kessel KPM, van Strijp JAG, Geisbrecht BV.

Arch Biochem Biophys. 2018 May 1;645:1-11. doi: 10.1016/j.abb.2018.03.007. Epub 2018 Mar 7.

10.

A structurally dynamic N-terminal region drives function of the staphylococcal peroxidase inhibitor (SPIN).

de Jong NWM, Ploscariu NT, Ramyar KX, Garcia BL, Herrera AI, Prakash O, Katz BB, Leidal KG, Nauseef WM, van Kessel KPM, van Strijp JAG, Geisbrecht BV.

J Biol Chem. 2018 Feb 16;293(7):2260-2271. doi: 10.1074/jbc.RA117.000134. Epub 2018 Jan 5.

11.

The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a Virulence Factor to Promote Bacterial Pathogenicity in vivo.

Koymans KJ, Goldmann O, Karlsson CAQ, Sital W, Thänert R, Bisschop A, Vrieling M, Malmström J, van Kessel KPM, de Haas CJC, van Strijp JAG, Medina E.

J Innate Immun. 2017;9(6):561-573. doi: 10.1159/000479100. Epub 2017 Sep 1.

12.

Immune evasion by a staphylococcal inhibitor of myeloperoxidase.

de Jong NWM, Ramyar KX, Guerra FE, Nijland R, Fevre C, Voyich JM, McCarthy AJ, Garcia BL, van Kessel KPM, van Strijp JAG, Geisbrecht BV, Haas PA.

Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9439-9444. doi: 10.1073/pnas.1707032114. Epub 2017 Aug 14.

13.

A human monoclonal antibody that specifically binds and inhibits the staphylococcal complement inhibitor protein SCIN.

Hoekstra H, Romero Pastrana F, Bonarius HPJ, van Kessel KPM, Elsinga GS, Kooi N, Groen H, van Dijl JM, Buist G.

Virulence. 2018 Jan 1;9(1):70-82. doi: 10.1080/21505594.2017.1294297. Epub 2017 May 8.

14.

LukMF' is the major secreted leukocidin of bovine Staphylococcus aureus and is produced in vivo during bovine mastitis.

Vrieling M, Boerhout EM, van Wigcheren GF, Koymans KJ, Mols-Vorstermans TG, de Haas CJ, Aerts PC, Daemen IJ, van Kessel KP, Koets AP, Rutten VP, Nuijten PJ, van Strijp JA, Benedictus L.

Sci Rep. 2016 Nov 25;6:37759. doi: 10.1038/srep37759.

15.

Staphylococcal Superantigen-Like Protein 1 and 5 (SSL1 & SSL5) Limit Neutrophil Chemotaxis and Migration through MMP-Inhibition.

Koymans KJ, Bisschop A, Vughs MM, van Kessel KP, de Haas CJ, van Strijp JA.

Int J Mol Sci. 2016 Jul 5;17(7). pii: E1072. doi: 10.3390/ijms17071072.

16.

The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.

Kuipers A, Stapels DA, Weerwind LT, Ko YP, Ruyken M, Lee JC, van Kessel KP, Rooijakkers SH.

Microbiology. 2016 Jul;162(7):1185-94. doi: 10.1099/mic.0.000293. Epub 2016 Apr 25.

17.

Staphylococcus aureus protects its immune-evasion proteins against degradation by neutrophil serine proteases.

Stapels DA, Kuipers A, von Köckritz-Blickwede M, Ruyken M, Tromp AT, Horsburgh MJ, de Haas CJ, van Strijp JA, van Kessel KP, Rooijakkers SH.

Cell Microbiol. 2016 Apr;18(4):536-45. doi: 10.1111/cmi.12528. Epub 2015 Oct 23.

PMID:
26418545
18.

Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes.

Spaan AN, Reyes-Robles T, Badiou C, Cochet S, Boguslawski KM, Yoong P, Day CJ, de Haas CJ, van Kessel KP, Vandenesch F, Jennings MP, Le Van Kim C, Colin Y, van Strijp JA, Henry T, Torres VJ.

Cell Host Microbe. 2015 Sep 9;18(3):363-70. doi: 10.1016/j.chom.2015.08.001. Epub 2015 Aug 27.

19.

Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3).

Koymans KJ, Feitsma LJ, Brondijk TH, Aerts PC, Lukkien E, Lössl P, van Kessel KP, de Haas CJ, van Strijp JA, Huizinga EG.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11018-23. doi: 10.1073/pnas.1502026112. Epub 2015 Aug 17.

20.

Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.

Spaan AN, Schiepers A, de Haas CJ, van Hooijdonk DD, Badiou C, Contamin H, Vandenesch F, Lina G, Gerard NP, Gerard C, van Kessel KP, Henry T, van Strijp JA.

J Immunol. 2015 Aug 1;195(3):1034-43. doi: 10.4049/jimmunol.1500604. Epub 2015 Jun 19.

21.

Bovine Staphylococcus aureus Secretes the Leukocidin LukMF' To Kill Migrating Neutrophils through CCR1.

Vrieling M, Koymans KJ, Heesterbeek DA, Aerts PC, Rutten VP, de Haas CJ, van Kessel KP, Koets AP, Nijland R, van Strijp JA.

MBio. 2015 Jun 4;6(3):e00335. doi: 10.1128/mBio.00335-15.

22.

Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation.

Braem SG, Rooijakkers SH, van Kessel KP, de Cock H, Wösten HA, van Strijp JA, Haas PJ.

J Innate Immun. 2015;7(4):364-74. doi: 10.1159/000369493. Epub 2015 Feb 10.

23.

A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia.

van den Berg S, Bonarius HP, van Kessel KP, Elsinga GS, Kooi N, Westra H, Bosma T, van der Kooi-Pol MM, Koedijk DG, Groen H, van Dijl JM, Buist G, Bakker-Woudenberg IA.

Int J Med Microbiol. 2015 Jan;305(1):55-64. doi: 10.1016/j.ijmm.2014.11.002. Epub 2014 Nov 11.

PMID:
25466204
24.

The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors.

Spaan AN, Vrieling M, Wallet P, Badiou C, Reyes-Robles T, Ohneck EA, Benito Y, de Haas CJ, Day CJ, Jennings MP, Lina G, Vandenesch F, van Kessel KP, Torres VJ, van Strijp JA, Henry T.

Nat Commun. 2014 Nov 11;5:5438. doi: 10.1038/ncomms6438.

25.

Neutrophil-Mediated Phagocytosis of Staphylococcus aureus.

van Kessel KP, Bestebroer J, van Strijp JA.

Front Immunol. 2014 Sep 26;5:467. doi: 10.3389/fimmu.2014.00467. eCollection 2014. Review.

26.

Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors.

Stapels DA, Ramyar KX, Bischoff M, von Köckritz-Blickwede M, Milder FJ, Ruyken M, Eisenbeis J, McWhorter WJ, Herrmann M, van Kessel KP, Geisbrecht BV, Rooijakkers SH.

Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13187-92. doi: 10.1073/pnas.1407616111. Epub 2014 Aug 26.

27.

Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface.

Ko YP, Kuipers A, Freitag CM, Jongerius I, Medina E, van Rooijen WJ, Spaan AN, van Kessel KP, Höök M, Rooijakkers SH.

PLoS Pathog. 2013;9(12):e1003816. doi: 10.1371/journal.ppat.1003816. Epub 2013 Dec 12.

28.

Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions.

Stemerding AM, Köhl J, Pandey MK, Kuipers A, Leusen JH, Boross P, Nederend M, Vidarsson G, Weersink AY, van de Winkel JG, van Kessel KP, van Strijp JA.

J Immunol. 2013 Jul 1;191(1):353-62. doi: 10.4049/jimmunol.1203243. Epub 2013 Jun 5.

29.

The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.

Spaan AN, Henry T, van Rooijen WJM, Perret M, Badiou C, Aerts PC, Kemmink J, de Haas CJC, van Kessel KPM, Vandenesch F, Lina G, van Strijp JAG.

Cell Host Microbe. 2013 May 15;13(5):584-594. doi: 10.1016/j.chom.2013.04.006.

30.

A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi.

Hoogeboom R, van Kessel KP, Hochstenbach F, Wormhoudt TA, Reinten RJ, Wagner K, Kater AP, Guikema JE, Bende RJ, van Noesel CJ.

J Exp Med. 2013 Jan 14;210(1):59-70. doi: 10.1084/jem.20121801. Epub 2013 Jan 7.

31.

Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis.

Laarman AJ, Mijnheer G, Mootz JM, van Rooijen WJ, Ruyken M, Malone CL, Heezius EC, Ward R, Milligan G, van Strijp JA, de Haas CJ, Horswill AR, van Kessel KP, Rooijakkers SH.

EMBO J. 2012 Aug 29;31(17):3607-19. doi: 10.1038/emboj.2012.212. Epub 2012 Jul 31.

32.

Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils.

Vida A, Bardoel B, Milder F, Majoros L, Sümegi A, Bácsi A, Vereb G, van Kessel KP, van Strijp JA, Antal-Szalmás P.

Immunol Lett. 2012 Aug 30;146(1-2):31-9. doi: 10.1016/j.imlet.2012.04.008. Epub 2012 May 2.

PMID:
22575527
33.

Identification of an immunomodulating metalloprotease of Pseudomonas aeruginosa (IMPa).

Bardoel BW, Hartsink D, Vughs MM, de Haas CJ, van Strijp JA, van Kessel KP.

Cell Microbiol. 2012 Jun;14(6):902-13. doi: 10.1111/j.1462-5822.2012.01765.x. Epub 2012 Feb 24.

PMID:
22309196
34.

Inhibition of Pseudomonas aeruginosa virulence: characterization of the AprA-AprI interface and species selectivity.

Bardoel BW, van Kessel KP, van Strijp JA, Milder FJ.

J Mol Biol. 2012 Jan 20;415(3):573-83. doi: 10.1016/j.jmb.2011.11.039. Epub 2011 Nov 29.

PMID:
22154939
35.

Pseudomonas evades immune recognition of flagellin in both mammals and plants.

Bardoel BW, van der Ent S, Pel MJ, Tommassen J, Pieterse CM, van Kessel KP, van Strijp JA.

PLoS Pathog. 2011 Aug;7(8):e1002206. doi: 10.1371/journal.ppat.1002206. Epub 2011 Aug 25.

36.

Neutralization of Neisseria meningitidis outer membrane vesicles.

Vida A, Troelstra A, Antal-Szalmás P, van Bommel TJ, Verheul AF, Verhoef J, van Kessel KP, van Strijp JA.

Inflamm Res. 2011 Sep;60(9):801-5. doi: 10.1007/s00011-011-0344-3. Epub 2011 May 24.

PMID:
21607761
37.

Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells.

Paauw A, Leverstein-van Hall MA, van Kessel KP, Verhoef J, Fluit AC.

PLoS One. 2009 Dec 29;4(12):e8240. doi: 10.1371/journal.pone.0008240.

38.

Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies.

Gustafsson E, Rosén A, Barchan K, van Kessel KP, Haraldsson K, Lindman S, Forsberg C, Ljung L, Bryder K, Walse B, Haas PJ, van Strijp JA, Furebring C.

Protein Eng Des Sel. 2010 Feb;23(2):91-101. doi: 10.1093/protein/gzp062. Epub 2009 Dec 3.

PMID:
19959567
39.

A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.

Prat C, Haas PJ, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP.

J Immunol. 2009 Nov 15;183(10):6569-78. doi: 10.4049/jimmunol.0801523. Epub 2009 Oct 21.

40.

Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus.

Gustafsson E, Haas PJ, Walse B, Hijnen M, Furebring C, Ohlin M, van Strijp JA, van Kessel KP.

BMC Immunol. 2009 Mar 11;10:13. doi: 10.1186/1471-2172-10-13.

41.

Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins.

Bestebroer J, van Kessel KP, Azouagh H, Walenkamp AM, Boer IG, Romijn RA, van Strijp JA, de Haas CJ.

Blood. 2009 Jan 8;113(2):328-37. doi: 10.1182/blood-2008-04-153882. Epub 2008 Oct 21.

42.

Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis.

Berbée JF, van der Hoogt CC, de Haas CJ, van Kessel KP, Dallinga-Thie GM, Romijn JA, Havekes LM, van Leeuwen HJ, Rensen PC.

Intensive Care Med. 2008 May;34(5):907-11. doi: 10.1007/s00134-008-1006-y. Epub 2008 Jan 30.

PMID:
18231776
43.

Staphylococcal complement evasion by various convertase-blocking molecules.

Jongerius I, Köhl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH.

J Exp Med. 2007 Oct 1;204(10):2461-71. Epub 2007 Sep 24.

44.

RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells.

Van Ewijk BE, Wolfs TF, Aerts PC, Van Kessel KP, Fleer A, Kimpen JL, Van der Ent CK.

Pediatr Res. 2007 Apr;61(4):398-403.

PMID:
17515861
45.

Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.

Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ.

Blood. 2007 Apr 1;109(7):2936-43.

46.

A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.

Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP.

J Immunol. 2006 Dec 1;177(11):8017-26.

47.

Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus.

Rooijakkers SH, Ruyken M, van Roon J, van Kessel KP, van Strijp JA, van Wamel WJ.

Cell Microbiol. 2006 Aug;8(8):1282-93.

PMID:
16882032
48.

Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.

Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ.

FEMS Microbiol Lett. 2006 May;258(2):290-6.

49.
50.

Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus.

Dürr MC, Kristian SA, Otto M, Matteoli G, Margolis PS, Trias J, van Kessel KP, van Strijp JA, Bohn E, Landmann R, Peschel A.

Cell Microbiol. 2006 Feb;8(2):207-17.

PMID:
16441432

Supplemental Content

Loading ...
Support Center